In a patient with new‑onset presyncope, documented supraventricular tachycardia episodes, and pre‑excitation on the resting electrocardiogram while taking metoprolol, is there any role for a stress (exercise) electrocardiogram?

No, stress EKG has limited utility in this patient and is NOT the appropriate next step.

In a patient with documented SVT, presyncope, and pre-excitation on resting ECG while on metoprolol, an invasive electrophysiology (EP) study is the appropriate diagnostic test—not a stress EKG. 1

Why Stress EKG is Not Indicated

The 2015 ACC/AHA/HRS guidelines clearly state that abrupt loss of pre-excitation during exercise testing is useful for identifying LOW-risk patients 1. However, this patient already has:

• Documented SVT episodes (not asymptomatic pre-excitation)
• Presyncope (symptomatic)
• Ongoing pre-excitation despite beta-blocker therapy

This clinical picture indicates symptomatic Wolff-Parkinson-White (WPW) syndrome, not asymptomatic pre-excitation where risk stratification might be debated.

Critical Evidence Against Stress Testing

• Diagnostic yield is extremely poor: Research shows stress testing has only 5.7% overall sensitivity for inducing SVT, even in patients with exercise-related symptoms 2
• Among patients with exercise-induced symptoms specifically, sensitivity reaches only 12% 2
• Stress EKG is designed to assess for intermittent loss of pre-excitation (indicating low-risk pathways), not to diagnose or risk-stratify already-documented SVT 1

The Correct Approach: EP Study

For symptomatic patients with pre-excitation, an EP study is useful to risk-stratify for life-threatening arrhythmic events 1. The EP study will:

1. Measure the accessory pathway's refractory period to assess risk of rapid ventricular rates during atrial fibrillation
2. Determine the shortest pre-excited RR interval during induced AF (≤250 ms indicates high risk)
3. Identify inducible sustained arrhythmias that could explain presyncope
4. Guide definitive treatment with catheter ablation

Why This Patient Needs EP Study Now

The combination of:

• Presyncope (suggests hemodynamically significant arrhythmia)
• Documented SVT
• Persistent pre-excitation on metoprolol

...places this patient at risk for pre-excited atrial fibrillation, which can degenerate into ventricular fibrillation and sudden cardiac death 3.

Critical Pitfall: Beta-Blocker Use

Metoprolol is problematic in WPW syndrome. The FDA label warns that metoprolol slows AV nodal conduction 4, which can paradoxically increase conduction down the accessory pathway during atrial fibrillation, potentially accelerating ventricular rates to dangerous levels.

• Beta-blockers do not block accessory pathway conduction
• They may facilitate more rapid ventricular rates during pre-excited AF by blocking the AV node preferentially

Recommended Management Algorithm

1. Discontinue metoprolol (contraindicated in pre-excitation with AF risk)
2. Refer for EP study to assess pathway characteristics and arrhythmia inducibility 1
3. Proceed to catheter ablation if EP study confirms high-risk features (reasonable Class IIa recommendation) 1
4. If ablation is declined or not feasible, consider antiarrhythmic drugs that block accessory pathway conduction (procainamide, ibutilide) rather than AV nodal blockers 1

The stress EKG would delay appropriate care and provide minimal diagnostic information in this symptomatic patient who requires definitive electrophysiologic assessment.